Guided Therapeutics, Inc.
GTHP
$0.29
$0.000.00%
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 185.00K | 115.00K | 388.00K | 194.00K | 275.00K |
Total Receivables | 8.00K | 2.00K | 3.00K | 2.00K | 2.00K |
Inventory | 595.00K | 633.00K | 633.00K | 636.00K | 632.00K |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 23.00K | 61.00K | 173.00K | 211.00K | 112.00K |
Total Current Assets | 811.00K | 811.00K | 1.20M | 1.04M | 1.02M |
|
|||||
Total Current Assets | 811.00K | 811.00K | 1.20M | 1.04M | 1.02M |
Net Property, Plant & Equipment | 112.00K | 139.00K | 164.00K | 189.00K | 213.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 17.00K | 17.00K | 17.00K | 17.00K | 17.00K |
Total Assets | 940.00K | 967.00K | 1.38M | 1.25M | 1.25M |
|
|||||
Total Accounts Payable | 2.29M | 2.19M | 2.13M | 2.13M | 2.18M |
Total Accrued Expenses | 916.00K | 812.00K | 784.00K | 735.00K | 630.00K |
Short-term Debt | 1.58M | 48.00K | 139.00K | 1.35M | 1.22M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 653.00K | 1.87M | 1.91M | 855.00K | 731.00K |
Total Finance Division Other Current Liabilities | 940.00K | 986.00K | 1.19M | 956.00K | 970.00K |
Total Other Current Liabilities | 940.00K | 986.00K | 1.19M | 956.00K | 970.00K |
Total Current Liabilities | 6.38M | 5.90M | 6.16M | 6.03M | 5.73M |
|
|||||
Total Current Liabilities | 6.38M | 5.90M | 6.16M | 6.03M | 5.73M |
Long-Term Debt | 35.00K | 76.00K | 63.00K | 66.00K | 82.00K |
Short-term Debt | 1.58M | 48.00K | 139.00K | 1.35M | 1.22M |
Capital Leases | -- | 20.00K | 49.00K | 76.00K | 104.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 6.41M | 6.00M | 6.27M | 6.17M | 5.92M |
|
|||||
Common Stock & APIC | 147.51M | 147.08M | 145.95M | 145.20M | 144.76M |
Retained Earnings | -155.03M | -154.17M | -153.71M | -153.01M | -152.32M |
Treasury Stock & Other | -132.00K | -132.00K | -132.00K | -132.00K | -132.00K |
Total Common Equity | -7.65M | -7.22M | -7.89M | -7.94M | -7.69M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 2.18M | 2.20M | 3.00M | 3.02M | 3.02M |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 2.18M | 2.20M | 3.00M | 3.02M | 3.02M |
|
|||||
Total Common Equity | -7.65M | -7.22M | -7.89M | -7.94M | -7.69M |
Total Preferred Equity | 2.18M | 2.20M | 3.00M | 3.02M | 3.02M |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -5.47M | -5.03M | -4.89M | -4.92M | -4.67M |
|